3SBio Announces Changes to its Board of Directors

SHENYANG, China, March 10 3SBio Inc.(Nasdaq: SSRX), a leading biotechnology company focused on researching,developing, manufacturing and marketing biopharmaceutical products primarilyin China, today announced changes to its board of directors (the "Board"). Ms.Liping Xu, Executive Director and Vice President, will retire from the Boardand her position as a company officer for health reasons, effective March 10,2010. Ms. Xu was one of the founders of the company and has been a director of3SBio and its predecessor company, Shenyang Sunshine, since 1993. Concurrently,effective March 10, 2010, Mr. Peiguo Cong will join the Board and serve as anindependent, non-executive director.

Mr. Dan Lou, Chairman of the Board, said, "On behalf of the Board, I wouldlike to thank Ms. Xu for her significant contributions as a founder, directorand key executive of the company. We wish her well with her future endeavors."He continued, "We are also pleased to welcome Mr. Cong to the Board as anindependent, non-executive director and look forward to his advice andcounsel."

Mr. Peiguo Cong has been the managing partner of Beijing Jun You Law Firmsince 1994. Mr. Cong also currently serves as a member of the FinancialSecurities Committee of the China National Lawyers Association, member of theAll China Federation of Industry and Commerce, director of the Chinese Societyof Mergers and Acquisitions, independent committee member of the CreditCommittee of the National Development Bank, and part-time professor at PekingUniversity. In addition, Mr. Cong serves as an independent director of ChinaSouthern Fund Management Company and Tianjin Lishen Battery Joint-Stock Co.,Ltd. Mr. Cong obtained his bachelor's degree in law and master's degree ineconomic law from Peking University.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China. For more information, please visit 3SBio on theweb at http://www.3sbio.com .

Safe Harbor Statement

This press release contains statements of a forward-looking nature. Thesestatements are made under the "safe harbor" provisions of the U.S. PrivateSecurities Litigation Reform Act of 1995. You can identify theseforward-looking statements by terminology such as "will," "expects,""anticipates," "future," "intends," "plans," "believes," "estimates" andsimilar statements. The accuracy of these statements may be impacted by anumber of business factors and uncertainties that could cause actual resultsto differ materially from those projected or anticipated, including factorsrelated to: the ability of the company to avoid disruption to its businesscaused by changes to the Board and management; the ability of the company torecruit and retain suitable members of the Board and management; and otherrisks outlined in 3SBio's filings with the Securities and Exchange Commission.3SBio does not undertake any obligation to update this forward-lookinginformation, except as required under applicable law.For more information, please contact: Investor Contacts 3SBio Inc. Bo Tan Chief Financial Officer Tel: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations Tel: +852-8191-6991 Email: ir@3SBio.com

SOURCE 3SBio Inc.